ClearBridge Investments’s Enzo Biochem, Inc. ENZ Stock Holding History

ClearBridge Investments’s Portfolio ENZ Stock Details ENZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-329	Closed	-$2K	–	1173
2016 Q4	$2K	Hold	329	–	–	﹤0.01%	1156
2016 Q3	$2K	Hold	329	–	–	﹤0.01%	1108
2016 Q2	$2K	Hold	329	–	–	﹤0.01%	1051
2016 Q1	$1K	Hold	329	–	–	﹤0.01%	1051
2015 Q4	$1K	Sell	329 -370,610	-100%	-$1.57M	﹤0.01%	1111
2015 Q3	$1.18M	Sell	370,939 -303,812	-45%	-$922K	﹤0.01%	720
2015 Q2	$2.04M	Sell	674,751 -46,231	-6%	-$130K	﹤0.01%	667
2015 Q1	$2.13M	Sell	720,982 -223,061	-24%	-$730K	﹤0.01%	681
2014 Q4	$4.19M	Sell	944,043 -115,278	-11%	-$550K	﹤0.01%	633
2014 Q3	$5.46M	Sell	1,059,321 -45,522	-4%	-$243K	0.01%	600
2014 Q2	$5.8M	Sell	1,104,843 -39,904	-3%	-$173K	0.01%	583
2014 Q1	$4.76M	Sell	1,144,747 -24,815	-2%	-$85.1K	0.01%	600
2013 Q4	$3.42M	Sell	1,169,562 -34,978	-3%	-$86.8K	﹤0.01%	621
2013 Q3	$3.04M	Sell	1,204,540 -77,502	-6%	-$184K	﹤0.01%	613
2013 Q2	$2.67M	Buy	+1,282,042	New	+$2.83M	﹤0.01%	609

Other funds holding ENZ

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

EGA

Evermore Global Advisors Summit, New Jersey $26.3M AUM 7.42% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ClearBridge Investments's ENZ Position: Q1 2017 in Review

ClearBridge Investments sold out of Enzo Biochem, Inc. (ENZ) in Q1 2017, closing a stake of 329 shares — an estimated $2K sold.

ClearBridge Investments first reported a position in ENZ in Q2 2013 and held it in 15 quarters. The position peaked at $5.8M in Q2 2014. 109 funds tracked by Wall St. Rank hold ENZ as of Q1 2017.

ClearBridge Investments reported no remaining Enzo Biochem, Inc. position as of Q1 2017 after selling out during the quarter.
ClearBridge Investments sold 329 Enzo Biochem, Inc. shares in Q1 2017, an estimated $2K.
ClearBridge Investments first reported a position in Enzo Biochem, Inc. in Q2 2013 and held it in 15 quarters.
ClearBridge Investments's Enzo Biochem, Inc. position peaked at $5.8M in Q2 2014.
109 funds tracked by Wall St. Rank held Enzo Biochem, Inc. as of Q1 2017.

Based on ClearBridge Investments's 13F filing for Q1 2017, filed 15 May 2017.